Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04607486
Other study ID # S60153
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 18, 2018
Est. completion date December 30, 2023

Study information

Verified date May 2024
Source Universitaire Ziekenhuizen KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The aim of this study is to investigate lower limb muscles after cerebrovascular accident


Description:

The aim of this study is to define and differentiate the changes in MMT properties related to the alterations in muscle tone of the lower limb in first-ever chronic stroke patients by using a 3D free-hand Ultrasonography (3DfUS) technique in combination with an instrumented spasticity assessment (IPSA). In these chronic stroke patients, the spontaneous neurological recovery is stabilized


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date December 30, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Definition of case population : o first ever stroke with spasticity of the lower limb. - Definition of control : - first ever stroke without spasticity of the lower limb - healthy aged-matched subjects Exclusion Criteria: - Musculoskeletal or neurological problems affecting the lower limb - Presence of other neurological pathology that could lead to spasticity, ataxia, dystonia - Cognitive problems that impede measurements - Severe co-morbidities - Peripheral spastic medication

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
3DfUS and IPSA of leg muscles
3DfUS technique enhances a conventional 2D US device into a platform capable of reconstructing 3D anatomical data sets. IPSA for quantification of hyper-resistance and its underlying components. The sensors in the IPSa include gyroscopes and accelerometers to measure joint angle and angular velocity, EMG to measure muscle activity, and a 3 degrees-of freedom force sensor to measure torque applied on the joint. clinical functional capacity = clinical evaluation of degree of independence, mobility and gait

Locations

Country Name City State
Belgium UZ Leuven Leuven

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Other Quantify the impairment caused by a stroke Evaluation of impairment caused by stroke by National Institute Health Stroke Scale 1 day
Other Assessments of functional independence in daily life in stroke patients and healthy subjects Evaluation of functional independence in daily life is assessed by the Barthel Index 1 day
Other Assessments of functional status after stroke Evaluation of functional status after stroke is assessed by the Functional Independence Measure 1 day
Other Assessesment of mobility in stroke patients Evaluation of mobility after stroke is assessed by the Rivermead Mobility Index 1 day
Other Assessment of transfer skills in stroke patients and healthy subjects Measurement of functional lower extremity strength and/or identify movement strategies in stroke patients and healthy subjects by The Five Times Sit to Stand Test 1 day
Other Assessment of the motor impairment in lower limbs of stroke patients Measurement of lower limb strength in stroke patients by the Motricity Index 1 day
Other Assessments of gait speed analysis in stroke patients and healthy subjects. 1 day Measurement of gait speed in stroke patients and healthy subjects by 5-Meter Walk Test at comfortable or self-selected gait speed.
Primary Muscle volume Estimation of muscle volume by 3D freehand ultrasonography. 1 day
Primary Muscle and Tendon Length Estimation of muscle volume by 3D freehand ultrasonography 1 day
Primary Echogenicity intensity Estimation of echogenicity intensity by 3D freehand ultrasonography on an 8-bit greyscale (256 values). 1 day
Primary Work [J] derived from the slow stretch Measurement of Work [J] by Instrumented Spasticity Assessment 1 day
Primary Muscle activity EMG [uV] derived from the fast stretch Measurement of Muscle activity EMG [uV] by Instrumented Spasticity Assessment 1 day
Primary Maximal velocity of performance (Vmax [deg/s]) Measurement of Maximal velocity of performance (Vmax [deg/s]) by Instrumented Spasticity Assessment 1 day
Primary Range of motion [deg] for slow stretch Measurement of Range of motion [deg] by Instrumented Spasticity Assessment 1 day
Primary Stiffness [Nm/deg] for slow stretch Measurement of Stiffness [Nm/deg] by Instrumented Spasticity Assessment 1 day
Primary Joint angle of catch [deg] from the fast stretch Measurement of Joint angle of catch [deg] from the fast stretch by Instrumented Spasticity Assessment 1 day
Primary Angle of EMG threshold [deg] from the fast stretch Measurement of Angle of EMG threshold [deg] by Instrumented Spasticity Assessment 1 day
Primary Intensity of catch derived from the fast stretch Measurement of Intensity of catch by Instrumented Spasticity Assessment 1 day
Secondary Clinical assessment of spasticity at fast stretch Estimation of spasticity by Modified Assessment Scale 1 day
Secondary Clinical assessment of spasticity angle at slow and fast stretch Estimation of spasticity by Tardieu Scale 1 day
See also
  Status Clinical Trial Phase
Completed NCT05477238 - Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls N/A
Completed NCT00046293 - ReoPro and Retavase to Treat Acute Stroke Phase 2
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT01116544 - Treatment of Chronic Stroke With AMES + EMG Biofeedback N/A
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Active, not recruiting NCT02563886 - Electrically Assisted Movement Therapy N/A
Recruiting NCT02446730 - Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01769326 - Influence of Timing on Motor Learning N/A
Recruiting NCT02557737 - Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities Phase 3
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT01656876 - The Effects of Mirror Therapy on Upper Extremity in Stroke Patients N/A
Completed NCT01423201 - Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
Completed NCT00542256 - tDCS and Physical Therapy in Stroke N/A
Withdrawn NCT00573092 - Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs N/A
Completed NCT00377689 - Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke Phase 2
Recruiting NCT00166751 - Sonographic Assessment of Laryngeal Elevation N/A
Terminated NCT00120289 - Niacin Plus Statin to Prevent Vascular Events Phase 3